{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/12/3311349/0/en/Press-Release-Sanofi-s-Tzield-approved-in-the-US-as-the-first-disease-modifying-therapy-for-patients-recently-diagnosed-with-stage-3-type-1-diabetes.html", "message": "News view counter 798110 successfully enlarged"}